Should Dividend Investors Eject AbbVie Stock?

By Dave Williamson – Jun 24, 2014 at 6:55PM

NYSE: ABBV

AbbVie

Market Cap

$296B

Today's Change

(-0.30%) -$0.51

Current Price

$167.29

Price as of April 25, 2024, 4:00 p.m. ET

World Cup fever spreads to dividend stock AbbVie

Dividend aristocrat spin-off AbbVie (NYSE: ABBV) has one of the highest yields in health care, but does that make it one of the sector's top dividend stocks?

In this video, Motley Fool Healthcare analyst David Williamson will be grading well known dividend stocks using a World Cup inspired grading system: a yellow card is a warning for investors, a red card is an ejection, and a "goal" happens if the stock looks like a winner.

Watch and find out the strengths and weaknesses of AbbVie's currently and if it should be ejected.

David Williamson owns shares of AbbVie.. The Motley Fool recommends Gilead Sciences. The Motley Fool owns shares of Gilead Sciences. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.